Michael Bookman - Net Worth and Insider Trading
Michael Bookman Net Worth
The estimated net worth of Michael Bookman is at least $4,396 dollars as of 2024-11-13. Michael Bookman is the GENERAL COUNSEL AND SECRETARY of Immuneering Corp and owns about 2,402 shares of Immuneering Corp (IMRX) stock worth over $4,396. Details can be seen in Michael Bookman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Bookman has not made any transactions after 2022-05-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Bookman
Michael Bookman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Bookman owns 3 companies in total, including Frequency Therapeutics Inc (FREQ) , Immuneering Corp (IMRX) , and Korro Bio Inc (KRRO) .
Click here to see the complete history of Michael Bookman’s form 4 insider trades.
Insider Ownership Summary of Michael Bookman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FREQ | Frequency Therapeutics Inc | 2021-01-19 | General Counsel and Secretary |
| IMRX | Immuneering Corp | 2022-05-17 | General Counsel and Secretary |
| KRRO | Korro Bio Inc | 2021-01-19 | General Counsel and Secretary |
Michael Bookman Latest Holdings Summary
Michael Bookman currently owns a total of 1 stock. Michael Bookman owns 2,402 shares of Immuneering Corp (IMRX) as of May 17, 2022, with a value of $4,396.
Latest Holdings of Michael Bookman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IMRX | Immuneering Corp | 2022-05-17 | 2,402 | 1.83 | 4,396 |
Holding Weightings of Michael Bookman
Michael Bookman Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Bookman has made a total of 2 transactions in Immuneering Corp (IMRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Immuneering Corp is the acquisition of 1,000 shares on May 17, 2022, which cost Michael Bookman around $4,880.
Insider Trading History of Michael Bookman
- 1
Michael Bookman Trading Performance
GuruFocus tracks the stock performance after each of Michael Bookman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Bookman is 47.67%. GuruFocus also compares Michael Bookman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Bookman within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Bookman's insider trading performs compared to the benchmark.
Performance of Michael Bookman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.3 | | | | | |
| Relative Return to S&P 500(%) | 23.09 | | | | | |
Michael Bookman Ownership Network
Ownership Network List of Michael Bookman
Ownership Network Relation of Michael Bookman
Michael Bookman Owned Company Details
What does Frequency Therapeutics Inc do?
Who are the key executives at Frequency Therapeutics Inc?
Michael Bookman is the General Counsel and Secretary of Frequency Therapeutics Inc. Other key executives at Frequency Therapeutics Inc include director & President and CEO David L. Lucchino , VP Finance & Operations Richard J. Mitrano , and Chief Scientific Officer Christopher R. Loose .
Frequency Therapeutics Inc (FREQ) Insider Trades Summary
Over the past 18 months, Michael Bookman made no insider transaction in Frequency Therapeutics Inc (FREQ). Other recent insider transactions involving Frequency Therapeutics Inc (FREQ) include a net sale of 97,675 shares made by David L. Lucchino , a net sale of 8,202 shares made by Richard J. Mitrano , and a net sale of 26,723 shares made by Christopher R. Loose .
In summary, during the past 3 months, insiders sold 0 shares of Frequency Therapeutics Inc (FREQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 132,600 shares of Frequency Therapeutics Inc (FREQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,600 shares.
Frequency Therapeutics Inc (FREQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Frequency Therapeutics Inc Insider Transactions
Michael Bookman Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Bookman. You might contact Michael Bookman via mailing address: C/o Frequency Therapeutics, Inc., 10 Presidential Way, 2nd Floor, Woburn Ma 01801.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
